Patients with type 2 diabetes, CKD, CAD, and COPD often carry elevated cardiovascular risk that may not be fully visible in standard care pathways. For value-based care organizations, undiagnosed arrhythmias in these high-burden populations may represent an overlooked opportunity to better understand risk, improve care coordination, and address avoidable utilization.
In this webinar, leaders from health economics, clinical programs, and population health will discuss real-world examples, emerging evidence, and recent initiatives examining the intersection of chronic disease burden and arrhythmia detection. The conversation will explore where cardiac risk may be missed today, the potential clinical and economic implications of undiagnosed arrhythmias, and how proactive identification may fit into broader strategies for improving outcomes, managing risk, and advancing value-based care performance.
